Evidence map›Paper›PMID 37293052›Full record

ArticlebioRxiv : the preprint server for biology2023

Retinoblastoma protein activity revealed by CRISPRi study of divergent Rbf1 and Rbf2 paralogs.

Ana-Maria Raicu, Patricia Castanheira, David N Arnosti

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ana-Maria RaicuCell and Molecular Biology Program, Michigan State University, East Lansing, MI.
Patricia CastanheiraDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI.
David N ArnostiDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI.
Michigan State University · US

Funding

Biochemical, Genomic and Computational Analysis of Transcriptional RepressionR01GM124137 · NIGMS · MICHIGAN STATE UNIVERSITY · PI ARNOSTI, DAVID N · 2017 to 2020
$1.2M
The Retinoblastoma corepressor family: precision targeting for discerning gene regulatory mechanisms in the Drosophila eyeF31HD105410 · NICHD · MICHIGAN STATE UNIVERSITY · PI RAICU, ANA-MARIA · 2021 to 2022
$67k
NICHD NIH HHS F31 HD105410NIGMS NIH HHS R01 GM124137
6 · The paper itself

Abstract

Retinoblastoma tumor suppressor proteins regulate the key transition from G1 to S phase of the cell cycle. The mammalian Rb family comprises Rb, p107, and p130, with overlapping and unique roles in gene regulation. Drosophila experienced an independent gene duplication event, leading to the Rbf1 and Rbf2 paralogs. To uncover the significance of paralogy in the Rb family, we used CRISPRi. We engineered dCas9 fusions to Rbf1 and Rbf2, and deployed them to gene promoters in developing Drosophila tissue to study their relative impacts on gene expression. On some genes, both Rbf1 and Rbf2 mediate potent repression, in a highly distance-dependent manner. In other cases, the two proteins have different effects on phenotype and gene expression, indicating different functional potential. In a direct comparison of Rb activity on endogenous genes and transiently transfected reporters, we found that only qualitative, but not key quantitative aspects of repression were conserved, indicating that the native chromatin environment generates context-specific effects of Rb activity. Our study uncovers the complexity of Rb-mediated transcriptional regulation in a living organism, which is clearly impacted by the different promoter landscapes and the evolution of the Rb proteins themselves.

Identifiers

PMID37293052
PMCPMC10245722
OpenAlexW4377138630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.